Doumar H, Mostafi H, Elhessni A, Touhami M, Mesfioui A
IBRO Neurosci Rep. 2025; 18:96-119.
PMID: 39866750
PMC: 11763173.
DOI: 10.1016/j.ibneur.2024.12.011.
Ouafi Z, Rhalem W, Habib N, Idrissi Azami A, Sehli S, Al Idrissi N
Bioinform Biol Insights. 2022; 16:11779322221145380.
PMID: 36582392
PMC: 9793058.
DOI: 10.1177/11779322221145380.
Wang X, Lin C, Wu S, Zhang T, Wang Y, Jiang Y
Front Immunol. 2022; 13:929222.
PMID: 36032146
PMC: 9399816.
DOI: 10.3389/fimmu.2022.929222.
Stefkov G, Cvetkovikj Karanfilova I, Stoilkovska Gjorgievska V, Trajkovska A, Geskovski N, Karapandzova M
Molecules. 2022; 27(3).
PMID: 35164240
PMC: 8838193.
DOI: 10.3390/molecules27030975.
Almeida C, Teixeira N, Correia-da-Silva G, Amaral C
Molecules. 2022; 27(1).
PMID: 35011388
PMC: 8746990.
DOI: 10.3390/molecules27010156.
Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?.
Filipiuc L, Ababei D, Alexa-Stratulat T, Pricope C, Bild V, Stefanescu R
Pharmaceutics. 2021; 13(11).
PMID: 34834237
PMC: 8625816.
DOI: 10.3390/pharmaceutics13111823.
Detrimental Effect of Cannabidiol on the Early Onset of Diabetic Nephropathy in Male Mice.
Carmona-Hidalgo B, Garcia-Martin A, Munoz E, Gonzalez-Mariscal I
Pharmaceuticals (Basel). 2021; 14(9).
PMID: 34577563
PMC: 8466593.
DOI: 10.3390/ph14090863.
An Evaluation of Understudied Phytocannabinoids and Their Effects in Two Neuronal Models.
Straiker A, Wilson S, Corey W, Dvorakova M, Bosquez T, Tracey J
Molecules. 2021; 26(17).
PMID: 34500785
PMC: 8434068.
DOI: 10.3390/molecules26175352.
Cannabinoids, Phenolics, Terpenes and Alkaloids of .
Radwan M, Chandra S, Gul S, ElSohly M
Molecules. 2021; 26(9).
PMID: 34066753
PMC: 8125862.
DOI: 10.3390/molecules26092774.
Biosynthesis and synthetic biology of psychoactive natural products.
Jamieson C, Misa J, Tang Y, Billingsley J
Chem Soc Rev. 2021; 50(12):6950-7008.
PMID: 33908526
PMC: 8217322.
DOI: 10.1039/d1cs00065a.
Cannabinoids and Cannabinoid Receptors: The Story so Far.
Shahbazi F, Grandi V, Banerjee A, Trant J
iScience. 2020; 23(7):101301.
PMID: 32629422
PMC: 7339067.
DOI: 10.1016/j.isci.2020.101301.
A systematic review of minor phytocannabinoids with promising neuroprotective potential.
Stone N, Murphy A, England T, OSullivan S
Br J Pharmacol. 2020; 177(19):4330-4352.
PMID: 32608035
PMC: 7484504.
DOI: 10.1111/bph.15185.
Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression.
Amada N, Yamasaki Y, Williams C, Whalley B
PeerJ. 2013; 1:e214.
PMID: 24282673
PMC: 3840466.
DOI: 10.7717/peerj.214.
Cannabidivarin is anticonvulsant in mouse and rat.
Hill A, Mercier M, Hill T, Glyn S, Jones N, Yamasaki Y
Br J Pharmacol. 2012; 167(8):1629-42.
PMID: 22970845
PMC: 3525866.
DOI: 10.1111/j.1476-5381.2012.02207.x.
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
Russo E
Br J Pharmacol. 2011; 163(7):1344-64.
PMID: 21749363
PMC: 3165946.
DOI: 10.1111/j.1476-5381.2011.01238.x.
[Hashish--chemistry and problems].
Bieniek D, Gau W, Korte F
Naturwissenschaften. 1974; 61(3):117-21.
PMID: 4826363
DOI: 10.1007/BF00606280.
Cannabivarichromene, a new cannabinoid with a propyl side chain in cannabis.
de Zeeuw R, Vree T, Breimer D, van Ginneken C
Experientia. 1973; 29(3):260-1.
PMID: 4708694
DOI: 10.1007/BF01926461.
